Back to search results

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

Abroad (travel likely)Recruiting

Conditions

Bladder Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • VA Long Beach Healthcare System, Long Beach, California, United States

    Contact: Study coordinator (Mina Behdad) · Mina.Behdad@va.gov

  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Amy Oppenheim) · Amy.Oppenheim@cshs.org · 310-423-3713
    Contact: Principal Investigator (Hideki Furuya, PhD)

  • UCLA Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Ankush Sachdeva) · asachdeva@mednet.ucla.edu

  • Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

    Contact: Study coordinator (Clemente Reyes) · clemente.reyesrodriguez@hoag.org · 949-791-3049

  • University of Rochester Medical Center, Rochester, New York, United States

    Contact: Study coordinator (Natalie Carroll) · Natalie_Carroll@URMC.Rochester.edu

  • UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

    Contact: Study coordinator (Maricruz Ibarra) · Maricruz.Ibarra@UTSouthwestern.edu

  • Nara Prefecture Seiwa Medical Center, Nara, Nara, Japan

    Contact: Study coordinator (Satoshi Anai, MD)

  • Nara Medical University, Nara, Japan

    Contact: Study coordinator (Takuto Shimizu, MD)
Study leads

  • Charles Rosser, MD

    Study Director

    Nonagen Bioscience Corporation

  • Hideki Furuya, PhD

    Principal Investigator

    Cedars-Sinai Medical Center

View source on ClinicalTrials.gov(opens in a new tab)